Home Cart 0 Sign in  

[ CAS No. 344591-91-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 344591-91-9
Chemical Structure| 344591-91-9
Structure of 344591-91-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 344591-91-9 ]

Related Doc. of [ 344591-91-9 ]

Alternatived Products of [ 344591-91-9 ]

Product Details of [ 344591-91-9 ]

CAS No. :344591-91-9 MDL No. :MFCD08701785
Formula : C5H6BF3N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :XPUNXPPXMANQGF-UHFFFAOYSA-N
M.W : 193.92 Pubchem ID :12056713
Synonyms :

Calculated chemistry of [ 344591-91-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.4
Num. rotatable bonds : 2
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 38.32
TPSA : 58.28 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 0.09
Log Po/w (WLOGP) : 0.27
Log Po/w (MLOGP) : -0.56
Log Po/w (SILICOS-IT) : -1.02
Consensus Log Po/w : -0.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.25
Solubility : 10.9 mg/ml ; 0.056 mol/l
Class : Very soluble
Log S (Ali) : -0.87
Solubility : 26.3 mg/ml ; 0.135 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.58
Solubility : 51.2 mg/ml ; 0.264 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.16

Safety of [ 344591-91-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 344591-91-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 344591-91-9 ]
  • Downstream synthetic route of [ 344591-91-9 ]

[ 344591-91-9 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 154471-65-5 ]
  • [ 344591-91-9 ]
YieldReaction ConditionsOperation in experiment
87%
Stage #1: With n-butyllithium; Triisopropyl borate In tetrahydrofuran; hexane at -78 - 20℃; for 3 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; hexane
2-methyl-5-trifluoromethyl-2H-pyrazole-3-boronic acid:
1-methyl-3-trifluoromethyl-1H-pyrazole (1.00 g, 6.66 mmol) was dissolved in THF (25 mL) in an oven-dried round bottom flask and cooled to-78 °C in an acetone/dry ice bath. 2.5 M n-butyl lithium/hexane (3.196 ml, 7.99 mmol) was added drop wise to the stirred solution followed by drop wise addition of triisopropyl borate (5.01 g, 26.64 mmol).
The mixture was warmed to room temperature and stirred for three hours.
The reaction mixture was adjusted to pH 6 with IN HCl solution followed by the removal of THF under vacuum.
The aqueous phase was extracted with EtOAc (3x100 ml).
The combined organic phase was washed with brine and dried over anhydrous MgS0(sub>4, filtered and evaporated to give 2-methyl-5-trifluoromethyl-2H-pyrazole-3-boronic acid (1.12 g, 5.80 mmol, 87 percent yield) as a white solid: LCMS m/z (percent) = 195 (M+H, 100).
%1
H NMR (400 MHz, DMSO-d6) δ: 8.37-8.40 (m, 2H), 7.57 (dd, J= 4.0 Hz, 1H), 4.06 (s, 3H).
Reference: [1] Patent: WO2005/12254, 2005, A1, . Location in patent: Page/Page column 135-136
  • 2
  • [ 121-43-7 ]
  • [ 154471-65-5 ]
  • [ 344591-91-9 ]
YieldReaction ConditionsOperation in experiment
64%
Stage #1: With n-butyllithium In tetrahydrofuran; hexanes; hexane at -78℃; for 1 h;
Stage #2: at -78 - 20℃;
Stage #3: With hydrogenchloride In tetrahydrofuran; hexanes; water at 20℃; for 1.5 h;
Preparation 7[1 -Methyl-3-(trifluoromethyl)-1 H-pyrazol-5-yllboronic acidTo a stirred solution of 1 -methyl-3-(thfluoronnethyl)-1 H-pyrazole (1 .89 g, 12.6 mmol) in anhydrous tetrahydrofuran (20 ml_) under nitrogen cooled to -78°C was added n- butyllithium (8.3 mL, 1 .6 M solution in hexanes, 13.2 mmol) slowly over 5 minutes. The resulting yellow solution was stirred at -78°C for 1 hour and trimethyl borate (1 .56 mL, 13.9 mmol) was then added slowly. The reaction flask was covered in foil and allowed to warm to room temperature for 16 hours. The white solution was quenched with aqueous 1 M hydrogen chloride solution (10 mL) and stirred at room temperature for 1 .5 hours. The mixture was extracted with ethyl acetate (2 x 30 mL), dried with anhydrous magnesium sulphate and evaporated in vacuo to give an off-white foam (2.1 1 g). The foam was triturated with dichloromethane, filtered and dried in vacuo to afford the title compound as a white solid (1 .57 g, 64percent).1H NMR (400 MHz, MeOH-d4): δ 4.04 (s, 3H), 6.89 (s, 1 H).LCMS Rt = 1 .1 1 minutes MS m/z 194 [MH]+ 192 [M-H]-,
Reference: [1] Patent: WO2012/7868, 2012, A2, . Location in patent: Page/Page column 75
[2] Patent: US2002/137633, 2002, A1,
[3] Patent: EP1108720, 2001, A1,
  • 3
  • [ 497832-99-2 ]
  • [ 344591-91-9 ]
  • [ 1138450-30-2 ]
Reference: [1] Patent: WO2009/43883, 2009, A1, . Location in patent: Page/Page column 46-47
  • 4
  • [ 497832-99-2 ]
  • [ 344591-91-9 ]
  • [ 1138450-30-2 ]
Reference: [1] Patent: WO2009/43883, 2009, A1, . Location in patent: Page/Page column 46-47
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 344591-91-9 ]

Fluorinated Building Blocks

Chemical Structure| 154471-65-5

[ 154471-65-5 ]

1-Methyl-3-(trifluoromethyl)-1H-pyrazole

Similarity: 0.65

Chemical Structure| 1138450-30-2

[ 1138450-30-2 ]

(1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid

Similarity: 0.62

Chemical Structure| 1426958-36-2

[ 1426958-36-2 ]

1-Butyl-3-(trifluoromethyl)-1H-pyrazole

Similarity: 0.59

Chemical Structure| 1006436-44-7

[ 1006436-44-7 ]

1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine

Similarity: 0.58

Chemical Structure| 2170881-31-7

[ 2170881-31-7 ]

(1-Isopropyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid

Similarity: 0.57

Organoboron

Chemical Structure| 847818-68-2

[ 847818-68-2 ]

(1,3-Dimethyl-1H-pyrazol-5-yl)boronic acid

Similarity: 0.82

Chemical Structure| 720702-41-0

[ 720702-41-0 ]

(1-Methyl-1H-pyrazol-5-yl)boronic acid

Similarity: 0.73

Chemical Structure| 1095080-54-8

[ 1095080-54-8 ]

(1-Ethyl-1H-pyrazol-5-yl)boronic acid

Similarity: 0.67

Chemical Structure| 847818-79-5

[ 847818-79-5 ]

1,3-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

Similarity: 0.66

Chemical Structure| 839714-33-9

[ 839714-33-9 ]

(1-Isopropyl-1H-pyrazol-5-yl)boronic acid

Similarity: 0.65

Trifluoromethyls

Chemical Structure| 154471-65-5

[ 154471-65-5 ]

1-Methyl-3-(trifluoromethyl)-1H-pyrazole

Similarity: 0.65

Chemical Structure| 1138450-30-2

[ 1138450-30-2 ]

(1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid

Similarity: 0.62

Chemical Structure| 1426958-36-2

[ 1426958-36-2 ]

1-Butyl-3-(trifluoromethyl)-1H-pyrazole

Similarity: 0.59

Chemical Structure| 1006436-44-7

[ 1006436-44-7 ]

1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine

Similarity: 0.58

Chemical Structure| 2170881-31-7

[ 2170881-31-7 ]

(1-Isopropyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid

Similarity: 0.57

Related Parent Nucleus of
[ 344591-91-9 ]

Pyrazoles

Chemical Structure| 847818-68-2

[ 847818-68-2 ]

(1,3-Dimethyl-1H-pyrazol-5-yl)boronic acid

Similarity: 0.82

Chemical Structure| 720702-41-0

[ 720702-41-0 ]

(1-Methyl-1H-pyrazol-5-yl)boronic acid

Similarity: 0.73

Chemical Structure| 1095080-54-8

[ 1095080-54-8 ]

(1-Ethyl-1H-pyrazol-5-yl)boronic acid

Similarity: 0.67

Chemical Structure| 847818-79-5

[ 847818-79-5 ]

1,3-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole

Similarity: 0.66

Chemical Structure| 839714-33-9

[ 839714-33-9 ]

(1-Isopropyl-1H-pyrazol-5-yl)boronic acid

Similarity: 0.65